40.01 0.00 0.00%
Official Close 3/17/2023 NAS

On Friday 03/17/2023 the closing price of the Sanara MedTech Inc Registered Shs share was $40.01 on NAS. Compared to the opening price on Friday 03/17/2023 on NAS of $40.59, this is a drop of 1.45%. Sanara MedTech Inc Registered Shs's market capitalization is $332.97 M by 8.30 M shares outstanding.
Is Sanara MedTech stock a Buy, Sell or Hold? Sanara MedTech stock has received a consensus rating of buy. The average rating score is and is based on 1 buy ratings, 0 hold ratings, and 0 sell ratings.
What was the 52-week low for Sanara MedTech stock? The low in the last 52 weeks of Sanara MedTech stock was 17.41. According to the current price, Sanara MedTech is 229.81% away from the 52-week low.
What was the 52-week high for Sanara MedTech stock? The high in the last 52 weeks of Sanara MedTech stock was 49.09. According to the current price, Sanara MedTech is 81.50% away from the 52-week high.
What are analysts forecasts for Sanara MedTech stock? The 1 analysts offering price forecasts for Sanara MedTech have a median target of 45.00, with a high estimate of 45.00 and a low estimate of 45.00. The median estimate represents a 88.91 difference from the last price of 40.01.

Sanara MedTech Stock Snapshot

40.00
Bid
2,100.00
Bid Size
40.88
Ask
200.00
Ask Size
3/17/2023
Date
8:00 PM
Time
13,492.00
Volume
40.79
Prev. Close
40.59
Open
332.97 M
Market Cap
8.30 M
Number of Shares
40.01
Day Low
40.85
Day High
40.01
17.41
52 Week Low
49.09
52 Week High
40.01
38.55
Free Float in %
0.28
EPS 2023

Sanara MedTech Historical Prices

Loading..
Date Open Close Daily High Daily Low
Price change over selected period: 0% 0

Sanara MedTech Analyst Data

Total Analysts: 1
Buy Ratings: 1 Neutral Ratings: 0 Sell Ratings: 0
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price *Price Target
Lowest: 45.00 Median: 45.00 Highest: 45.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.

Sanara MedTech Analyst Opinions

06/30/21 Cantor Fitzgerald
Maintained Buy $45

Sanara MedTech Estimates* in USD

  2023 2024
Revenue 76 108
Dividend - -
Dividend Yield (in %) - -
EPS 0.28 2.38
P/E Ratio 142.89 16.81
EBIT 4 25
EBITDA - -
Net Profit 2 19
Net Profit Adjusted - -
Pre-Tax Profit 3 24
Net Profit (Adjusted) - -
EPS (Non-GAAP) ex. SOE - -
EPS (GAAP) 0.28 2.38
Gross Income 64 93
Cash Flow from Investing -1 -
Cash Flow from Operations 6 -
Cash Flow from Financing - -
Cash Flow per Share - -
Free Cash Flow - -
Free Cash Flow per Share - -
Book Value per Share - -
Net Debt - -
Research & Development Exp. 6 7
Capital Expenditure 1 -
Selling, General & Admin. Exp. 52 60
Shareholder’s Equity 35 -
Total Assets 40 -
  Previous Quarter
ending 12/31/22
Current Quarter
ending 03/31/23
Next Quarter
ending 06/30/23
Current Year
ending 12/31/23
Next Year
ending 12/31/24
Earnings Estimates
No. of Analysts 1 1 1 1 1
Average Estimate -0.260 USD -0.120 USD 0.020 USD 0.280 USD 2.380 USD
Year Ago - -0.410 USD -0.420 USD - 0.280 USD
Publish Date 3/20/2023 5/16/2023 8/14/2023 - -
Revenue Estimates
No. of Analysts 1 1 1 1 1
Average Estimate 15 USD 16 USD 18 USD 76 USD 108 USD
Year Ago - 8 USD 10 USD - 76 USD
Publish Date 3/20/2023 5/16/2023 8/14/2023 - -
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Sanara MedTech Insider Activity

Name Date shares traded shares held Price type (sell/buy) option
Fleming Zachary B. 03/01/2023 1,736.00 43,198.00 n/a Buy No
Fleming Zachary B. 03/01/2023 6,988.00 41,462.00 n/a Buy No
McNeil Michael D. 03/01/2023 4,217.00 23,468.00 n/a Buy No
McMahon Rebecca E 03/01/2023 2,410.00 9,796.00 n/a Buy No
Fleming Zachary B. 12/01/2022 325.00 34,474.00 22.97 Sell No
Fleming Zachary B. 12/01/2022 1,471.00 34,799.00 30.79 Sell No
McNeil Michael D. 12/01/2022 253.00 19,251.00 22.97 Sell No
Bowman Shawn M. 12/01/2022 4,414.00 11,469.00 n/a Sell No
Bowman Shawn M. 12/01/2022 260.00 15,883.00 22.97 Sell No
Bowman Shawn M. 12/01/2022 82.00 16,143.00 30.79 Sell No
Bowman Shawn M. 12/01/2022 1,101.00 16,225.00 36.86 Sell No
Bowman Shawn M. 12/01/2022 1,224.00 17,326.00 30.79 Sell No
McNeil Michael D. 12/01/2022 865.00 19,504.00 30.79 Sell No
Fleming Zachary B. 11/07/2022 417.00 36,270.00 33.00 Sell No
Fleming Zachary B. 11/03/2022 563.00 36,687.00 33.00 Sell No
Fleming Zachary B. 11/01/2022 20.00 37,250.00 33.02 Sell No
Bowman Shawn M. 09/21/2022 340.00 18,550.00 28.56 Sell No
Bowman Shawn M. 09/21/2022 660.00 18,890.00 27.54 Sell No
Nixon Ronald T 07/06/2022 4,113.00 27,279.00 n/a Buy No
DeSutter Robert Andrew 07/06/2022 5,256.00 12,587.00 n/a Buy No
Thorpe Kenneth E 07/06/2022 5,027.00 16,945.00 n/a Buy No
Salamone Ann Beal 07/06/2022 4,113.00 14,544.00 n/a Buy No
TANZBERGER ERIC D 07/06/2022 5,027.00 7,364.00 n/a Buy No
STUCKERT JAMES W 07/06/2022 4,799.00 833,976.00 n/a Buy No
Ortwein Sara N 07/06/2022 4,799.00 11,280.00 n/a Buy No

Sanara MedTech Dividend Calendar

Date Name Dividend *yield Currency
2021 Sanara MedTech Inc Registered Shs - - USD
2020 Sanara MedTech Inc Registered Shs - - USD
2019 Sanara MedTech Inc Registered Shs - - USD
2018 Sanara MedTech Inc Registered Shs - - USD
2017 Sanara MedTech Inc Registered Shs - - USD
2016 Sanara MedTech Inc Registered Shs - - USD
2015 Sanara MedTech Inc Registered Shs - - USD
2014 Sanara MedTech Inc Registered Shs - - USD
2013 Sanara MedTech Inc Registered Shs - - USD
2012 Sanara MedTech Inc Registered Shs - - USD
2011 Sanara MedTech Inc Registered Shs - - USD
2010 Sanara MedTech Inc Registered Shs - - USD
2009 Sanara MedTech Inc Registered Shs - - USD
*Yield of the Respective Date

Sanara MedTech Inc Registered Shs Calendar

Event Estimate Info Date
Earnings Report -0.260 USD Q4 2022 Earnings Release 03/20/2023
Press Conference - 03/21/2023
Earnings Report -0.120 USD Q1 2023 Earnings Release 05/16/2023
Earnings Report 0.020 USD Q2 2023 Earnings Release 08/14/2023
Earnings Report - Q3 2023 Earnings Release 11/16/2023
Earnings Report - Q4 2023 Earnings Release 03/27/2024

Sanara MedTech Inc Registered Shs Past Events

Event Actual EPS Info Date
Press Conference - - 11/15/2022
Press Conference - - 08/16/2022
Press Conference - - 05/17/2022
Press Conference - - 03/31/2022

Sanara MedTech Profile

Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.

Moody’s Daily Credit Risk Score

Risk
  • Low
  • Medium
  • High
7
Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

Sanara MedTech Shareholder

Owner in %
The Catalyst Group, Inc. 41.15
Freefloat 38.55
James Wadhams Stuckert, MBA 11.57
S. Oden Howell 5.91
Opaleye Management, Inc. 2.71
Vanguard Group, Inc. (Subfiler) 1.15
Vanguard Total Stock Market Index Fund 0.84
Maven Investment Partners US Ltd. (US) 0.84
Fidelity Management & Research Co. LLC 0.82
Fidelity Small Cap Stock Fund 0.72
EAM Investors LLC 0.66
Monashee Investment Management LLC 0.53
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.